🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 67011T300 (prev. 67011T201 )
- Market Cap
- Micro Cap
- Previous Symbol
- NVOSD (changed 2/23/2021)
Business: Novo Integrated Sciences’ wholly owned subsidiaries provides multidisciplinary primary health care related services and products, across Canada, through corporate-owned clinics, a contracted network of affiliate clinics, eldercare centric homes, and certain medical technology capabilities including telemedicine and remote patient monitoring.
Notes: November 06, 2023 -- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced that the Company will undertake a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective immediately after the close of trading on the Nasdaq Capital Market ("Nasdaq") on November 6, 2023 (the "Effective Date") and the Company’s common stock is expected to begin trading on Nasdaq on a Reverse Stock Split-adjusted basis on November 7, 2023, under the new CUSIP number, 67011T300.
Company Contact
- CEO
- Robert Mattacchione
- CFO
- Vivek Sethi
- Headquarters
- 11120 NE 2nd Street, Suite 100, Bellevue, WA 98004
- Phone
- 206-617-9797
- Investor Relations
- 206-617-9797 · info@novointegrated.com